Literature DB >> 25278991

Prasugrel-induced hypersensitivity skin reaction.

Soo-Han Kim1, Sang-Don Park1, Yong-Soo Baek1, Seon-Young Lee1, Sung-Hee Shin1, Sung-Il Woo1, Dae-Hyeok Kim1, Jun Kwan1.   

Abstract

We report a case of hypersensitivity skin reaction to prasugrel. The patient exhibited a generalized skin rash after treatment with prasugrel, which was resolved after discontinuation of prasugrel and substitution to clopidogrel. Clopidogrel was successfully administered as an alternative to prasugrel without any signs of further hypersensitivity.

Entities:  

Keywords:  Clopidogrel; Exanthema; Hypersensitivity; Prasugrel; Thienopyridine

Year:  2014        PMID： 25278991      PMCID： PMC4180615          DOI： 10.4070/kcj.2014.44.5.355

Source DB:  PubMed          Journal:  Korean Circ J        ISSN： 1738-5520            Impact factor:   3.243


  8 in total

1.  Characterization of clopidogrel hypersensitivity reactions and management with oral steroids without clopidogrel discontinuation.

Authors:  Asim N Cheema; Atif Mohammad; Tony Hong; Henry R Jakubovic; Gurpreet S Parmar; Waseem Sharieff; M Bernadette Garvey; Michael J B Kutryk; Neil P Fam; John J Graham; Robert J Chisholm
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

2.  Desensitization to prasugrel: cardiology's increased need for allergy consultation.

Authors:  Jack Leon-Max Mutnick
Journal:  Ann Allergy Asthma Immunol       Date:  2011-12-03       Impact factor: 6.347

3.  Prasugrel-induced rash.

Authors:  Abhishek J Deshmukh; Sadip Pant; Jeffery Cook; Rajesh Sachdeva; David Rutlen; Barry F Uretsky
Journal:  Ann Pharmacother       Date:  2012-07-17       Impact factor: 3.154

4.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

Authors:  S R Mehta; S Yusuf; R J Peters; M E Bertrand; B S Lewis; M K Natarajan; K Malmberg; H Rupprecht; F Zhao; S Chrolavicius; I Copland; K A Fox
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

5.  Allergic reactions to clopidogrel and cross-reactivity to other agents.

Authors:  Juzar Lokhandwala; Patricia J M Best; Yvette Henry; Peter B Berger
Journal:  Curr Allergy Asthma Rep       Date:  2011-02       Impact factor: 4.806

6.  Prasugrel versus clopidogrel in patients with acute coronary syndromes.

Authors:  Stephen D Wiviott; Eugene Braunwald; Carolyn H McCabe; Gilles Montalescot; Witold Ruzyllo; Shmuel Gottlieb; Franz-Joseph Neumann; Diego Ardissino; Stefano De Servi; Sabina A Murphy; Jeffrey Riesmeyer; Govinda Weerakkody; C Michael Gibson; Elliott M Antman
Journal:  N Engl J Med       Date:  2007-11-04       Impact factor: 91.245

7.  Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study.

Authors:  M E Bertrand; V Legrand; J Boland; E Fleck; J Bonnier; H Emmanuelson; M Vrolix; L Missault; S Chierchia; M Casaccia; L Niccoli; A Oto; C White; M Webb-Peploe; E Van Belle; E P McFadden
Journal:  Circulation       Date:  1998-10-20       Impact factor: 29.690

8.  Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrel.

Authors:  Juzar O Lokhandwala; Patricia J M Best; Joseph H Butterfield; Kimberly A Skelding; Thomas Scott; James C Blankenship; Jeremy W Buckley; Peter B Berger
Journal:  Circ Cardiovasc Interv       Date:  2009-07-22       Impact factor: 6.546
  8 in total
  1 in total

1.  Intolerance to Multiple P2Y12 Inhibitors Following Percutaneous Coronary Intervention.

Authors:  Mina Shnoda; Kinan Kassar; Deanna L Huffman; Vijaya Sanikommu; Indu Poornima
Journal:  Cureus       Date:  2021-02-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.